Biosimilar Uptake in Medicare Advantage vs Traditional Medicare

被引：3

作者：

Kozlowski, Steven ^{[1
,2
]}

Kwist, Andrew ^{[3
]}

McEvoy, Rowan ^{[3
]}

Koirala, Nirabh ^{[3
]}

Chillarige, Yoganand ^{[3
]}

Kelman, Jeffrey A. ^{[4
]}

Graham, David J. ^{[2
]}

机构：

[1] US FDA, Off Biotechnol Prod, Off Pharmaceut Qual, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,White Oak Bldg 71,Room 223, Silver Spring, MD 20993 USA

[2] US FDA, US Food & Drug Adm, Silver Spring, MD 20993 USA

[3] Acumen LLC, Burlingame, CA USA

[4] Ctr Medicare & Medicaid Serv, Washington, DC USA

来源：

JAMA HEALTH FORUM | 2023年 / 4卷 / 12期

关键词：

D O I：

10.1001/jamahealthforum.2023.4335

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

This cross-sectional study uses Traditional Medicare and Medicare Advantage claims data to evaluate uptake of biosimilars relative to their reference products.

引用

页数：4

共 50 条

[1] Filgrastim and infliximab biosimilar uptake in Medicare Advantage compared with Traditional Medicare, 2016-2019
Liu, Angela
Xuan, Andrew
Socal, Mariana
Anderson, Gerard
Anderson, Kelly E.
JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2024, 30 (01): : 15 - 21
[2] Medicare Advantage And Traditional Medicare Differences
Kahn, James G.
HEALTH AFFAIRS, 2023, 42 (10) : 1468 - 1468
[3] Medicare-Covered Services Near the End of Life in Medicare Advantage vs Traditional Medicare
Nicholas, Lauren Hersch
Fischer, Stacy M.
Arbaje, Alicia I.
Perraillon, Marcelo Coca
Jones, Christine D.
Polsky, Daniel
JAMA HEALTH FORUM, 2024, 5 (07):
[4] Care for Food-Insecure Enrollees in Medicare Advantage vs Traditional Medicare
Park, Sunchul
Langellier, Brent A.
AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (07): : E234 - +
[5] Radiotherapy Utilization in Traditional Medicare and Medicare Advantage
Hogan, Jacob
Orav, E. John
Zhang, Tianfeng
Spektor, Alexander
Zheng, Jie
Tsai, Thomas C.
Lam, Miranda B.
JAMA NETWORK OPEN, 2025, 8 (04)
[6] Characteristics of Decedents in Medicare Advantage and Traditional Medicare
Byhoff, Elena
Harris, John A.
Ayanian, John Z.
JAMA INTERNAL MEDICINE, 2016, 176 (07) : 1020 - 1023
[7] Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare Advantage
Karaca-Mandic, Pinar
Chang, Jessica
Go, Ronald
Schondelmeyer, Stephen
Weisdorf, Daniel
Jeffery, Molly Moore
HEALTH AFFAIRS, 2019, 38 (11) : 1887 - 1892
[8] Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare
Casebeer, Adrianne W.
Schwartz, Richard
Patel, Harmit
Caplan, Ariel
Bhattacharya, Rituparna
Long, Charron
Sharma, Anup
Changamire, Tich
Uribe, Claudia
Stemple, Chuck
Thomas, Kali
Newsom, Mark
Painter, Phil
Shrank, William
Brown, Courtney R.
AMERICAN JOURNAL OF MANAGED CARE, 2021, 27 (04): : 140 - +
[9] Role of Patient Sorting in Avoidable Hospital Stays in Medicare Advantage vs Traditional Medicare
Xu, Jianhui
Anderson, Kelly E.
Liu, Angela
Miller, Brian J.
Polsky, Daniel
JAMA HEALTH FORUM, 2023, 4 (11): : E233931
[10] Comparison of the Quality of Hospitals That Admit Medicare Advantage Patients vs Traditional Medicare Patients
Meyers, David J.
Trivedi, Amal N.
Mor, Vincent
Rahman, Momotazur
JAMA NETWORK OPEN, 2020, 3 (01)

← 1 2 3 4 5 →